zadnja posodobitev :
07/07/2025
raziskovalne skupine - Asahikawa Medical University, Asahikawa, Japan   pdf  
Japonska
univerza
Asahikawa Medical University, Asahikawa, Japan
Asahikawa
Email
Viri   Viri   (1)  
1
Real-World Nivolumab Wastage and Leftover Drug Stability Assessment to Facilitate Drug Vial for Cost Savings.
Fukudo M, Ishikawa R, Mishima K, Ono T, Matsumoto S, Tasaki Y. (mfukudo@asahikawa-med.ac.jp)
JCO Oncology Practice - 2020 - ; 16, 10: e1134-e1142.

Seznami   molekule študiral   (1)  
rak drog Brizgalka Nivolumab

  Mentions Légales
BESbswy